Mutational Processes Molding the Genomes of 21 Breast CancersSerena Nik‐Zainal, Michael S. Neuberger, Andrew Menzies et al.|Cell|2012Cited by 2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L. Telli, Andrea L. Richardson, Kirsten M. Timms et al.|Clinical Cancer Research|2016Cited by 1.2k
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast CancerDaniel P. Silver, Judy E. Garber, Andrea L. Richardson et al.|Journal of Clinical Oncology|2010Cited by 983
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging AgentsNicolai J. Birkbak, Andrea L. Richardson, Zhigang C. Wang et al.|Cancer Discovery|2012Cited by 684
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugsAndrea Marion Marquard, Nicolai J. Birkbak, Aron C. Eklund et al.|Biomarker Research|2015Cited by 321